Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gary R. Morrow, PhD, MS
University of Rochester
Study Chair - Martin M. Oken, MD
CCOP - Metro-Minnesota
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
45 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto Nacional de Enfermedades Neoplasicas
Lima, Peru
- Pretoria Academic Hospital
Pretoria, South Africa
- Mbccop - Gulf Coast
Mobile, Alabama, United States
- Mobile Infirmary Medical Center
Mobile, Alabama, United States
- Cedar Rapids Oncology Associates
Cedar Rapids, Iowa, United States
- Mccreery Cancer Center at Ottumwa Regional
Ottumwa, Iowa, United States
- Mercy Medical Center - Sioux City
Sioux City, Iowa, United States
- Siouxland Hematology-Oncology Associates, Llp
Sioux City, Iowa, United States
- St. Luke'S Regional Medical Center
Sioux City, Iowa, United States
- Ccop - Wichita
Wichita, Kansas, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Green Bay Oncology, Limited - Escanaba
Escanaba, Michigan, United States
- Dickinson County Healthcare System
Iron Mountain, Michigan, United States
- Ccop - Kalamazoo
Kalamazoo, Michigan, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- Ccop - Kansas City
Kansas City, Missouri, United States
- Hunterdon Regional Cancer Center at Hunterdon Medical Center
Flemington, New Jersey, United States
- Warren Hospital
Phillipsburg, New Jersey, United States
- Ccop - Hematology-Oncology Associates of Central New York
East Syracuse, New York, United States
- St. Vincent'S Comprehensive Cancer Center - Manhattan
New York, New York, United States
- Our Lady of Mercy Medical Center Comprehensive Cancer Center
The Bronx, New York, United States
- Ccop - Southeast Cancer Control Consortium
Goldsboro, North Carolina, United States
- Mercy Cancer Center at Mercy Medical Center
Canton, Ohio, United States
- Metrohealth Cancer Care Center at Metrohealth Medical Center
Cleveland, Ohio, United States
- Ccop - Columbus
Columbus, Ohio, United States
- Ccop - Dayton
Dayton, Ohio, United States
- Ccop - Columbia River Oncology Program
Portland, Oregon, United States
- Penn State Cancer Institute at Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
- Lewistown Hospital
Lewistown, Pennsylvania, United States
- Mount Nittany Medical Center
State College, Pennsylvania, United States
- Chester County Hospital
West Chester, Pennsylvania, United States
- Ccop - Greenville
Greenville, South Carolina, United States
- Avera Cancer Institute
Sioux Falls, South Dakota, United States
- Medical X-Ray Center, Pc
Sioux Falls, South Dakota, United States
- Sanford Cancer Center at Sanford Usd Medical Center
Sioux Falls, South Dakota, United States
- Ccop - Northwest
Tacoma, Washington, United States
- Green Bay Oncology, Limited at St. Mary'S Hospital
Green Bay, Wisconsin, United States
- Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
Green Bay, Wisconsin, United States
- St. Mary'S Hospital Medical Center - Green Bay
Green Bay, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 1997
- Primary completion
- 30 Apr 2011
- Completion
- 31 Jan 2012
- Last update posted
- 11 Nov 2015
- Registered enrollment
- 212
- Registry id
- NCT00002850
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.